Increasing CHADS₂ scores may attenuate the benefit of novel oral anticoagulants versus warfarin in reducing intracranial bleeding.
Davide
D
Capodanno
Piera
P
Capranzano
Giuseppe
G
Giacchi
Valeria
V
Calvi
Corrado
C
Tamburino
D000925:Anticoagulants / Q000008:administration & dosage*; D001281:Atrial Fibrillation / Q000188:drug therapy* / Q000473:pathology*; D006801:Humans; D012720:Severity of Illness Index
D000925:Anticoagulants